Bertrand Routy

Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer

Lisa Derosa, Matthew D. Hellmann, Marco Spaziano et al. · Annals of Oncology · 2018 · 835 citations · Full text

Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer

Lisa Derosa, Bertrand Routy, Andrew Maltez Thomas et al. · Nature Medicine · 2022 · 587 citations · Full text

Pd-1 Blockade, Medicine, Immunology +9

Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

Miles C. Andrews, Connie P.M. Duong, Vancheswaran Gopalakrishnan et al. · Nature Medicine · 2021 · 388 citations · Full text

Dysbiosis, Health Sciences, Mucosal Immunology +13

Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial

Bertrand Routy, John Lenehan, Wilson H. Miller et al. · Nature Medicine · 2023 · 385 citations

Tumor Immunology, Anti-pd-1 Immunotherapy, Cancer Immunosurveillance +12

The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non–Small Cell Lung Cancer

Taiki Hakozaki, Corentin Richard, Arielle Elkrief et al. · Cancer Immunology Research · 2020 · 278 citations